Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2026-2034

Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A6082

Market Overview:

The global bioabsorbable stents market size reached USD 467.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 815.9 Million by 2034, exhibiting a growth rate (CAGR) of 6.19% during 2026-2034.

Report Attribute
Key Statistics
Base Year
2025
Forecast Years
2026-2034
Historical Years
2020-2025
Market Size in 2025 USD 467.5 Million
Market Forecast in 2034 USD 815.9 Million
Market Growth Rate (2026-2034) 6.19%

Bioabsorbable stents (BRS) are coated with an antiproliferative drug or gene that dissolves over time to restore vessel patency and permit remodeling while retaining recoil. It helps in regulating blood flow at branch points and limiting the amount of blood to areas of the vascular network while maintaining the flow at low perfusion. It also improves lesion imaging with cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In addition, it leaves no residual scaffold, reduces vessel irritation and inflammation, and facilitates repeat treatments to the same site. As a result, BRS finds extensive applications in hospitals and cardiac centers across the globe.

Bioabsorbable Stents Market Size

To get more information on this market Request Sample

Bioabsorbable Stents Market Trends:

The growing prevalence of cardiovascular diseases due to an unhealthy diet, physical inactivity, and excessive consumption of tobacco and alcohol represents one of the factors driving the market. Moreover, there is a rise in the utilization of percutaneous coronary intervention (PCI) procedures to open a blocked artery for carrying oxygen-rich blood through the body. This, along with the expanding healthcare industry, is contributing to the growth of the market. Besides this, the increasing awareness among the masses about the benefits of bioabsorbable stents is offering lucrative growth opportunities to industry investors. In addition, the growing demand for minimally invasive procedures due to less postoperative pain, fewer operative and postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS) fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. They are also focusing on developing polymer-based stents, which is expected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioabsorbable stents market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on biomaterial, absorption rate, application and end user.

Breakup by Biomaterial:

  • Polymer-based Bioabsorbable Stents
  • Metal-based Bioabsorbable Stents
     

Breakup by Absorption Rate:

  • Slow-Absorption Stents
  • Fast-Absorption Stents
     

Breakup by Application:

Bioabsorbable Stents Market By Application

Access the comprehensive market breakdown Request Sample

Breakup by End User:

  • Hospitals
  • Cardiac Centers
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report provides a comprehensive analysis of the competitive landscape in the global bioabsorbable stents market with detailed profiles of all major companies, including:

  • Arterius Limited
  • B. Braun SE
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences
  • Reva Medical, LLC
  • Terumo Corporation

Report Coverage:

Report Features Details
Base Year of the Analysis 2025
Historical Period 2020-2025
Forecast Period 2026-2034
Units Million USD
Segment Coverage Biomaterial, Absorption Rate, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences, Reva Medical, LLC, Terumo Corporation, etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global bioabsorbable stents market was valued at USD 467.5 Million in 2025.

We expect the global bioabsorbable stents market to exhibit a CAGR of 6.19% during 2026-2034.

The rising prevalence of cardiovascular diseases, along with the increasing adoption of bioabsorbable stents in hospitals, as they facilitate repeat treatments to the same site, is primarily driving the global bioabsorbable stents market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective cardiological treatment procedures to reduce the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals or medical equipment, thereby negatively impacting the global market for bioabsorbable stents.

Based on the biomaterial, the global bioabsorbable stents market has been divided into polymer-based bioabsorbable stents and metal-based bioabsorbable stents, where polymer-based bioabsorbable stents exhibit a clear dominance in the market.

Based on the absorption rate, the global bioabsorbable stents market can be categorized into slow-absorption stents and fast-absorption stents. Currently, slow-absorption stents hold the majority of the total market share.

Based on the application, the global bioabsorbable stents market has been segregated into coronary artery disease and peripheral artery disease, where coronary artery disease currently exhibits a clear dominance in the market. 

Based on the end user, the global bioabsorbable stents market can be bifurcated into hospitals and cardiac centers. Currently, hospitals account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global bioabsorbable stents market include Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences, Reva Medical, LLC, and Terumo Corporation.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2026-2034
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials